EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections

Matt Driedger iD, Nick Daneman iD, Kevin Brown iD, Wayne L Gold, Sarah C J Jorgensen, Colleen Maxwell, Kevin L Schwartz iD, Andrew M Morris, Deva Thiruchelvam, Bradley Langford, Elizabeth Leung, Derek MacFadden

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02630-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Matt Driedger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Ottawa , Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Cross Infection, Bacteremia, COVID-19, Sepsis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Clinical Evaluative Sciences (ICES), Ontario Ministry of Health and Long-Term Care (MOHLTC), Ontario Health Data Platform.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has likely influenced the epidemiology of bacterial infections through wide-ranging changes to clinical practices and infection control and prevention interventions. We sought to determine how the detection and incidence of bloodstream infections (BSIs) have been influenced by the pandemic. We performed a retrospective analysis of blood culture data in the province of Ontario, Canada, from 1 January 2017 to 31 December 2020. Outcomes included a weekly incidence of blood culture tests, BSIs, and contaminant results. Results were stratified by hospital, community, and long-term care (LTC) settings. An interrupted time series analysis using segmented regression models was used to determine changes in outcome incidence/prevalence during the pre- and peri-pandemic periods. Of the 14,083,853 individuals included, 129,329 (0.92%) developed a bloodstream infection. The blood culture ordering rate increased during the pandemic in the hospital setting only [Incidence rate ratio (IRR) 1.09, 95% confidence interval (CI) 1.01–1.19]. There was a decline in the incidence of community-acquired (IRR 0.95, 95% CI 0.91–0.99) and LTC-acquired (IRR 0.85, 95% CI 0.76–0.94) BSIs. Hospital-acquired BSIs were unchanged. The proportion of blood culture contaminants increased in the community (7% increase, P < 0.01) and LTC settings (14% increase, P < 0.05). There was decreased incidence of community-acquired Streptococcus pneumoniae (IRR 0.43, 95% CI 0.33–0.57) and Staphylococcus aureus (IRR 0.91, 95% CI 0.84–0.99) bacteremia. Pandemic-related changes in the performance of blood cultures and the epidemiology of BSIs have implications for current and future pandemic antimicrobial use, healthcare resource allocation, and hospital and laboratory policies. IMPORTANCE Bacterial infections are a significant cause of morbidity and mortality worldwide. In the wake of the COVID-19 pandemic, previous studies have demonstrated pandemic-related shifts in the epidemiology of bacterial bloodstream infections (BSIs) in the general population and in specific hospital systems. Our study uses a large, comprehensive data set stratified by setting [community, long-term care (LTC), and hospital] to uniquely demonstrate how the effect of the COVID-19 pandemic on BSIs and testing practices varies by healthcare setting. We showed that, while the number of false-positive blood culture results generally increased during the pandemic, this effect did not apply to hospitalized patients. We also found that many infections were likely under-recognized in patients in the community and in LTC, demonstrating the importance of maintaining healthcare for these groups during crises. Last, we found a decrease in infections caused by certain pathogens in the community, suggesting some secondary benefits of pandemic-related public health measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross InfectionBacteremiaCOVID-19SepsisBacterial InfectionsHumansPandemicsBlood CultureBacteria

Stichwörter der Autor:innen

COVID-19blood culturesbloodstream infectionsepidemiologypandemic

Autor:innen und Institutionen

  • Department of Medicine, The University of Ottawa , Ottawa, Ontario, Canada.
  • Sunnybrook Health Sciences Centre, University of Toronto , Toronto, Ontario, Canada.
  • ICES , Toronto, Ontario, Canada.
  • Public Health Ontario , Toronto, Ontario, Canada.
  • Dalla Lana School of Public Health , Toronto, Ontario, Canada.
  • The University Health Network , Toronto, Ontario, Canada.

ORCID-Profile: Matt Driedger, Nick Daneman, Kevin Brown, Kevin L Schwartz

Förderung

  • Institute for Clinical Evaluative Sciences (ICES)
  • Ontario Ministry of Health and Long-Term Care (MOHLTC)
  • Ontario Health Data Platform
  • Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)

Zitieren

APA

Driedger, M., Daneman, N., Brown, K., Gold, W. L., Jorgensen, S. C., Maxwell, C., Schwartz, K. L., Morris, A. M., Thiruchelvam, D., Langford, B., Leung, E., & MacFadden, D. (2023). The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02630-23

Vancouver

Driedger M, Daneman N, Brown K, Gold WL, Jorgensen SC, Maxwell C, et al. The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02630-23

BibTeX
@article{Driedger2023,
  author = {Driedger, Matt and Daneman, Nick and Brown, Kevin and Gold, Wayne L and Jorgensen, Sarah C J and Maxwell, Colleen and Schwartz, Kevin L and Morris, Andrew M and Thiruchelvam, Deva and Langford, Bradley and Leung, Elizabeth and MacFadden, Derek},
  title = {The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02630-23}
}
Kostenlos starten →